Get access

Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6–7, 2011, Arlington, Virginia§

Authors


  • Gregory S. Weinstein was a consultant for Intuitive Surgical, Inc., which ended November 2011.

  • Harry Quon received an honorarium and has served as a consultant in he past to Intuitive Surgical, Inc.

  • §

    Val J. Lowe has received surgical support from GE HealthCare, Siemens Molecular Imaging, and AVID Radiopharmaceuticals/Lilly.

Abstract

Recent advances now permit resection of many pharyngeal tumors through the open mouth, an approach that can greatly reduce the morbidity of surgical exposure. These transoral techniques are being rapidly adopted by the surgical community and hold considerable promise. On November 6–7, 2011, the National Cancer Institute sponsored a Clinical Trials Planning Meeting to address how to further investigate the use of transoral surgery, both in the good prognosis human papillomavirus (HPV)–initiated oropharyngeal cancers, and in those with HPV-unrelated disease. The proceedings of this meeting are summarized. © 2012 Wiley Periodicals, Inc. Head Neck, 2012

Get access to the full text of this article

Ancillary